In a perfect world (such as between identical twins), the HLA typing is a 10/10 or 12/12 match.
In most transplants:
The better the match: The less likely the recipient’s immune system will recognize the organ as “foreign,” leading to a longerlasting transplant and potentially lower doses of antirejection medications.
A “mismatch”: If the donor has an HLA type (e.g., HLAA2) that the recipient’s immune system has already developed antibodies against (high MFI), the transplant is considered highrisk.
Modern medicine has become so good at managing mismatches with drugs (like Tacrolimus and Mycophenolate) that a “mismatch” is no longer a dealbreaker. As long as the Virtual Crossmatch is negative—meaning the recipient does not have preexisting antibodies against those specific mismatches—the transplant can still be very successful.
Bu sayfanın altına da CTA ekleyebiliriz: “Contact us to discuss your transplant compatibility”